Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Clinical trial NCT03497806 · COMPLETED

Trial details

NCT number: NCT03497806
Sponsor: Finch Research and Development LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridium Difficile Infection Recurrent Clostridium Difficile Infection C. Diff CDI Recurrent C. Diff rCDI C. Difficile Recurrent CDI FMT Fecal Microbiota Fecal Transplant

Start date: 2018-05-01
Primary completion: 2020-12-31
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.